Incidence of Descemet Membrane Detachment Post GATT by AS OCT

Sponsor
Cairo University (Other)
Overall Status
Active, not recruiting
CT.gov ID
NCT05932940
Collaborator
(none)
30
1
1
8
3.8

Study Details

Study Description

Brief Summary

detection of Incidence of Descemet membrane detachment post gonioscopy-assisted transluminal trabeculotomy by anterior segment optical coherence tomography in patients with open angle glaucoma.

Condition or Disease Intervention/Treatment Phase
  • Procedure: Gonioscopy-Assisted Transluminal Trabeculotomy
N/A

Detailed Description

In our study, which should include 30 eyes with OAG who underwent 360 GATT Screening for Descemet Membrane Detachment will be done by Anterior Segment Optical coherence Tomography using SD-OCT: Optovue RTVue (Optovue Inc., Fremont, CA, USA) for the angle day 1 post operative for all patients and 1 week post operative in cases with Descemet membrane detachment to check for spontaneous resolution.

One month post-operative the patients underwent

  • Best corrected visual acuity (BCVA) using decimal.

  • IOP measurement using GAT.

Study Design

Study Type:
Interventional
Actual Enrollment :
30 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Intervention Model Description:
detection of incidence of Descemet membrane detachment post gonioscopy-assisted transluminal trabeculotomy by anterior segment optical coherence tomography in patients with open angle glaucoma.detection of incidence of Descemet membrane detachment post gonioscopy-assisted transluminal trabeculotomy by anterior segment optical coherence tomography in patients with open angle glaucoma.
Masking:
None (Open Label)
Primary Purpose:
Diagnostic
Official Title:
Incidence of Descemet Membrane Detachment Post Gonioscopy-Assisted Transluminal Trabeculotomy by Anterior Segment Optical Coherence Tomography in Patients With Open Angle Glaucoma
Actual Study Start Date :
Dec 1, 2022
Actual Primary Completion Date :
Apr 1, 2023
Anticipated Study Completion Date :
Aug 1, 2023

Arms and Interventions

Arm Intervention/Treatment
Experimental: GATT group

detection of incidence of Descemet membrane detachment post gonioscopy-assisted transluminal trabeculotomy by anterior segment optical coherence tomography in patients with open angle glaucoma.

Procedure: Gonioscopy-Assisted Transluminal Trabeculotomy
Ab interno angle surgery one of MIGS to lower IOP

Outcome Measures

Primary Outcome Measures

  1. Incidence of Descemet Membrane detachment post GATT [4 months]

    Incidence of Descemet membrane Detachment post Gonioscopy-Assisted Transluminal Trabeculotomy

Secondary Outcome Measures

  1. Amount of reduction of IOP and Glaucoma NGM [4 months]

    Amount of reduction of intraocular pressure and Number of Glaucoma medications

  2. Incidence of Hyphema post GATT [4 months]

    Incidence of Hyphema post Gonioscopy-Assisted Transluminal Trabeculotomy

  3. Incidence of Descemet membrane detachment post gonioscopy-assisted transluminal trabeculotomy by anterior segment optical coherence tomography in patients with open angle glaucoma. [4 months]

    Incidence of Descemet membrane detachment post gonioscopy-assisted transluminal trabeculotomy by anterior segment optical coherence tomography in patients with open angle glaucoma.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 70 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  1. Age 18 - 70 years.

  2. Patients with open angle glaucoma undergoing gonioscopy assisted transluminal trabeculotomy.

Exclusion Criteria:
  1. Patients with with open angle glaucoma and aphakia.

  2. Patients with Congenital Glaucoma.

  3. Patients with open angle glaucoma undergoing phaco -gonioscopy-assisted transluminal trabeculotomy.

  4. Patients with neovascular glaucoma.

  5. Patients with pigmentary Glaucoma.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Facility of medicine , Cairo University Cairo Almanial Egypt

Sponsors and Collaborators

  • Cairo University

Investigators

  • Principal Investigator: Fayrouz Aboalazayem, phD, Cairo University

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Marwa Elsayed Soliman Ahmed, Opthalmology resident Cairo University, Cairo University
ClinicalTrials.gov Identifier:
NCT05932940
Other Study ID Numbers:
  • MS-275-2022
First Posted:
Jul 6, 2023
Last Update Posted:
Jul 6, 2023
Last Verified:
Jul 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Marwa Elsayed Soliman Ahmed, Opthalmology resident Cairo University, Cairo University
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jul 6, 2023